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Introduction: In view of the detailed histologic evaluation of prostate cancer (PC), it is 
usually advisable to provide a “second opinion” to confi rm diagnosis. This study aimed 
to compare the Gleason score (GS) of initial diagnosis versus that of histopathologic 
review of patients with PC. The secondary objective was to compare initial GS versus 
histopathologic review versus post - surgical histopathology.
Material and methods: Retrospective study based on chart review of patients with PC 
that attended the Uro - oncology Department of Hospital das Clínicas - UNICAMP 
- Campinas, Brazil, from April, 2002, to April, 2012. Data were divided in groups: 
patients with biopsies performed elsewhere, biopsies after pathological review and his-
topathological results following retropubic radical prostatectomy (RRP). These were 
evaluated in relation to GS difference using Fleis’s Kappa concordance coeffi cient.
Results: 402 PC patients, with a median age of 66 years, were evaluated. Reviewed GS 
showed worsening, with accuracy of 61.2%, and Kappa concordance value = 0.466. 
Among 143 patients submitted to surgery, GS varied widely, regarding initial evalu-
ation, review and post - surgical RRP. Joint concordance of evaluations was weak 
(Kappa = 0.216), mainly due to almost no existence concordance between initial evalu-
ation and following RRP (Kappa = 0.041).
Conclusion: There is a great histopathological variation of initial GS versus reviewed 
GS. There is also a better correlation of reviewed GS and post - surgical GS than with 
initial GS. The second opinion by an uropathologist improves diagnosis and should be 
advised for better therapeutic decision.
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INTRODUcTION
Increase in life expectancy and determina-
tion of prostatic specifi c antigen (PSA) elevated the 
incidence of PC in the last decades. Prognosis is de-
termined by histologic grade, PSA and digital rectum 
exam, of which GS is the most important to determi-
ne the best treatment for specifi c - risk groups (1-3).
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 Since an accurate histologic evaluation 
is mandatory, in many occasions it is necessa-
ry a “second opinion” to confirm the diagno-
sis and to determine the GS, and occasionally, 
the analysis by an uro - pathologist is decisive 
(4-6). Its recommendation is increasing due to 
its benefits, such as more efficient therapies for 
different tumors, lowering costs using correct 
treatments, and lower risks of legal exposure of 
the physician, for example (7).
 At the uro - oncology ambulatory of Hos-
pital das Clinicas - UNICAMP, all external his-
topathologic exams of PC are routinely revised. 
Each patient of that ambulatory with initial ex-
ternal diagnosis of PC provides the material for 
confirmation by the Pathology Department, before 
a new biopsy. The primary goal of this study was 
to compare initial diagnostic GS versus histologic 
review of patients with PC referred to our tertiary 
center. The second objective was to compare ini-
tial diagnostic GS versus post - surgical exams of 
patients submitted to RRP.
MATERIALS AND METHODS
 This is a retrospective study exclusively ba-
sed on the review of 402 charts of patients with PC 
attended at the uro - oncology Department of HC - 
UNICAMP from April 2002 to April 2012.
The following data were collected: age, ini-
tial total PSA and after review, digital rectum exam, 
histopathologic findings, in special GS, D’Amico 
risk grade and treatments.
 In 2005, during the analyzed period, the In-
ternational Society of Urologic Pathology published 
modifications of the original system of PC grading. 
More restrict criteria were stablished for Gleason 3 
classification, lowering its incidence in the patho-
logical exams. Also, a secondary pattern was de-
termined as worse prognosis observed at the needle 
biopsy. Since the present study was performed in a 
tertiary uro - oncology referral center, the patholo-
gy department adjusted to the new criteria, as soon 
as they were published in scientific literature. The-
refore, charts analyzed after 2005 adopted the GS 
changes proposed by ISUP (8). Data were divided in 
groups, according to histologic exam momentum: 
Group 1 (external initial analysis) - initial results of 
external prostate biopsies, performed at non - ter-
tiary clinics and hospitals, of patients referred to the 
ambulatory of uro - oncology; Group 2 (histopatho-
logic review) - results obtained at the initial pros-
tatic biopsies, using the same material (lamina and 
blocks) brought by the patients from the origin 
clinics, that were reviewed by a pathologist mem-
ber of the Department of Pathology of our tertiary 
center; Group 3 (after RRP) - results of the patho-
logical exam of the surgical block removed after 
RRP only of patients submitted to surgical treat-
ment in the same tertiary uro - oncology service. 
Following data collection, groups were compared 
in relation to GS differences.
Inclusion criteria: patients with 40 to 80 
years old, with PC diagnosis and previous biopsy 
elsewhere, that were referred to the uro - onco-
logy ambulatory and were reviewed before defi-
nitive treatment.
Exclusion criteria: patients with diagno-
sis and initial prostatic biopsy provided by that 
tertiary center that did not need histopathologic 
review. Also, patients with lack of histologic exa-
ms, histopathologic findings or relevant clinical 
information were also excluded; 75% of data were 
considered sufficient. Data were analyzed descrip-
tively and initially in an Excel chart and poste-
riorly were analyzed by SPSS software. Demogra-
phic data are presented in number and percentage. 
GS is showed in tables and frequency graphics.
 Fleis’s Kappa concordance coefficient of 
GS were calculated in different groups to verify 
initial biopsy concordance (Group-1), second 
opinion (Group-2) and after surgery (Group-3). 
Kappa values vary from - 1 to + 1. The higher the 
Kappa value, the stronger is the concordance of 
the analyzed groups. Kappa ± 1 refers to perfect 
concordance, Kappa = 0 refers to random concor-
dance and Kappa values < 0 refer to low concor-
dance, lower than expected randomly. Values ≥ 
0.75 refer to good concordance (9).
RESULTS
Median age of the 402 patients was 66 ye-
ars and most showed initial and reviewed PSA ≤ 
10 ng / dL (Table-1). Most used treatments were ra-
diotherapy and RRP (19% and 17.5% respectively) 
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followed by bilateral orquiectomy and hormone 
therapy (7.8% and 7%).
 When the 402 patients were analyzed, 
initial GS and after review varied, with a worse-
ning of histologic classification (Table-2 / Figu-
re-1). Accuracy between initial GS and revision 
was only 61.2% with Kappa = 0.466 and CI 95% 
(0.427 - 0.495).
 Considering only the 143 patients sub-
mitted to surgery, GS varied widely from initial 
evaluation, review and after RRP (Table-3 / Figu-
re-2). Accuracy and concordance values between 
initial GS and after RRP were the lowest among 
all theee comparisons: initial versus review, ini-
tial versus after RRP and review versus after RRP, 
with estimate 21% and - 0.041, respectively. Co-
joint concordance of three evaluations was con-
sidered weak (Kappa = 0.216) mainly due to the 
almost inexistent accordance between initial and 
RRP (Kappa = 0.041).
Table 1 - Patients characteristics.
Variables Frequency %
Age (years) 
40 to 49 14 3.5
50 to 59 76 19
60 to 69 181 45
70 to 80 131 32.5
Medium (SD) 
65.4 (8.4) 66 (40 - 80)
Median (min - max) 
Initial PSA 
≤ 10 173 43
> 10 and ≤ 20 129 32
> 20 100 25
Medium (SD) 
18.6 (47.8) 12 (3 - 544)
Median (min - max) 
Review PSA
≤ 10 168 42
> 10 and ≤ 20 99 24.5
> 20 135 33.5
Medium (SD) 
21.5 (47.4) 12.5 (3.3 - 545)
Median (min - max) 
DIScUSSION
 Several studies have shown the importance 
of a second opinion by experienced uro - onco - pa-
thologists, in order to obtain an accurate PC diagno-
sis (10, 11). Histological review may propose a more 
precise treatment of patients: from watchful waiting 
or active surveillance, to invasive therapies such as 
surgery, radiotherapy and hormone - therapy.
 In this study, the degree of discrepancy of 
initial GS following review was close to 45%. Many 
causes may explain this alteration: lack of familia-
rity of non - tertiary hospital pathologists with the 
analyzed samples, difficulty to evaluate biopsies with 
Gleason score 4 and 5 after the change of classifi-
cation proposed in 2005, and the bias due to the re-
view performed by the same team that analyzed the 
histologic material following RRP. Also, the size of 
the biopsy samples, number of positive samples and 
percentage of cancer in each positive sample, since 
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they were not individualized in a different vial, may 
also alter the final diagnosis and GS, preventing a 
better analysis on the place the sample was originally 
from (12). Also, Epstein and cols observed that 5% of 
needle biopsies described atypical glands suspected 
of carcinoma with a higher probability of change af-
ter expert review (4).
 One of the first studies on second histopa-
thologic opinion of PC was published by Epstein 
in 1996. After reviewing 535 patients, 7 (1.3%) 
were reclassified as benign, avoiding subsequent 
treatments, with significant savings, better quali-
ty of life, absence of collateral effects of surgery 
and radiotherapy and the possible reclassifica-
tion to minimum tumor volume with indication 
to watchful waiting (13).
 In 2001, Murphy and cols (7) reviewed 150 
patients and observed 29 discrepancies in diagnos-
tic interpretation and 14 resulted in change of tre-
atment. The author was unaware if second opinion 
was an error of interpretation or a true difference 
of opinion, but concluded that treatment of pa-
tients was affected and therefore the review should 
be ordered as part of a complete evaluation.
 Wayment and cols (11) in 2011 evaluated 
the use of second opinion in patients with urologi-
cal tumors. Among 264 patients, 213 had material 
for reanalysis, being 117 patients with PC (55%), 
83 with bladder cancer (39%), 5 with testicle tumor 
(2%), 5 with pelvis or ureteral tumor (2%), 2 retro-
peritoneal tumors (1%) and 1 renal tumor (0.5%). 
In 22 patients, it was observed disagreement of ini-
tial and reviewed diagnosis (10.3%), being 18 clas-
sified as important and 4 with lower importance, 
reinforcing the role of histopathologic review by 
uro - pathologists not only of PC but of all urolo-
gic tumors (7).
 Berg et al. (14) stated that PC histopatholo-
gy is closely associated to variability among different 
professionals. In their study, they analyzed prosta-
tic biopsies review and compared initial reports, re-
viewed reports and RRP results in 350 patients.
Figure 1 - Initial and post - review GS of all patients.
Table 2 - Initial and post - review GS of all patients.
Gleason
Initial Review
Frequency % Frequency %
2 + 2 1 0.3 0 0
2 + 3 2 0.5 0 0
3 + 2 4 1 0 0
3 + 3 141 35 110 27.4
3 + 4 137 34 178 44.3
4 + 3 38 9.5 16 4
4 + 4 27 6.7 65 16.2
4 + 5 31 7.7 32 8
5 + 4 4 1 0 0
5 + 5 0 0 0 0
3 + 5 17 4.3 1 0.2
Total 402 100 402 100
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Figure 2 - Initial, post - review and after RRP GS only of 
patients submitted to surgery.
 Cury et al. (15) stressed that exact deter-
mination of GS at prostate biopsy is crucial to 
choose the correct treatment of PC, particularly 
of well - differentiated tumors, where imprecision 
may result in a very conservative treatment.
 In our study, comparing analysis of GS by 
general pathologists and by tertiary centers uro-
pathologists, it was possible to find a frequency 
of 34% of Gleason 3 + 3 determined by general 
pathologists and a drop to 27.4% of that GS by 
uropathologists analysis. It was also observed a 
significant increase of GS 3 + 4 (from 34% to 
44.3%), reduction of Gleason 4 + 3 (from 9.5% to 
4%) and a considerable increase of Gleason 4 + 4 
(from 6.8% to 16.2%), respectively. These results 
are in agreement with the literature data, showing 
that the review by uropathologists or experienced 
pathologists in urological diseases usually incre-
ases GS value. When this analysis was performed 
only in patients submitted to RPP, the number of 
patients with GS 3 + 3 significantly reduced from 
51.7% to 7.7%. On the other hand, GS 4 + 4 incre-
ased from 12.6% to 51.7%, respectively.
 Even considering the study limitations, in 
special retrospective observation bias and GS alte-
ration that alter homogeneity of information, the re-
sults confirmed the importance of review for better 
Table 3 - Initial and post - review GS and after RRP only of patients submitted to surgery.
Gleason
Initial Review Post - RRP
Frequency % Frequency % Frequency %
2 + 2 1 0.7 0 0.0 0 0.0
2 + 3 2 1.4 0 0.0 0 0.0
3 + 2 4 2.8 0 0.0 0 0.0
3 + 3 74 51.7 43 30.1 11 7.7
3 + 4 30 21.0 41 28.7 27 18.9
4 + 3 9 6.3 2 1.4 10 7.0
4 + 4 18 12.6 54 37.8 74 51.7
4 + 5 2 1.4 3 2.1 17 11.9
5 + 4 2 1.4 0 0.0 1 0.7
5 + 5 0 0.0 0 0.0 3 2.1
3 + 5 1 0.7 0 0.0 0 0.0
Total 143 100 143 100 143 100
 For Berg et al. (14), PC histopathology is sig-
nificantly associated to variability among different 
observers. In their study, they analyzed reviews of 
prostatic biopsies compared to initial biopsies reports, 
and RPP material in 350 patients. GS accordan-
ce between initial report and reviewed was 76.9%. 
Reviewed tumors had higher GS grades in 25% of 
patients, when primary GS = 6. Tumors were under-
-classified in 3% and 10.3% of patients with primary 
GS = 7 and ≥ 8, respectively. Also, in that study, the-
re was a significant tendency to higher concordance 
between reviewed GS and surgical sample following 
RRP, which was also observed in our study.
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treatment of patients, as well as the need to improve 
the reproducibility of biopsy results, by continued 
education and specific training of pathologists.
cONcLUSIONS
 In this study, histopathologic review sho-
wed great histopathologic variation of initial GS 
versus reviewed. It also showed better correlation 
of reviewed classification with surgical sample 
than with initial GS. Therefore, it is concluded 
that uropathologist expert review is important for 
precise diagnosis and correct treatment, that must 
whenever possible be recommended before thera-
peutic decision.
ABBREvIATIONS
PC = Prostate cancer
GS = Gleason Score
RRP = Retropubic radical prostatectomy
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